PATRICK M. GUINEE, D.V.M.

Advise and support biotech start-up companies with critical operational insights, planning and execution to ensure maximal impact to science and minimize capital burn rates.

• Reduced operational costs through collaborative management initiatives -significant (+)capital impact
• Led operational team in development, rollout, and management of new product lines, positive revenue

• Proactive, results-driven portfolio leader responsible for strategic and operational cross-functional guidance to lead pre-clinical and clinical programs.
• Direct accountability for IT, Facilities, Project Management, Patient Advocacy, Lab Operations, Emergency Response Team, and Office Management. Committed to developing each team member through positive engagement and two-way feedback.
• Vital member of the Senior Leadership Team and Joint Steering Committees to our CDMOs and CROs. Chosen from a pool of 15 to oversee strategy and the operational implementation of manufacturing changes critical to go forward plans that culminated in a 2022 restructuring.
• Highly sought out leader at all levels for mentorship, problem-solving, and career guidance.

• Led cross-functional 5yr corporate plan with direct oversight of facilities, laboratory, and information technology operations.
• Key member of Technical Operations leadership team interfacing with CMC and external clinical manufacturing teams to improve operational focus, communication and performance.
• Built state-of-the art pre-clinical laboratory and expanded office space to 40k sqft in Cambridge. Developed blueprint to build a stand-alone GMP facility to manufacture commercial grade AAV gene therapy drugs.
• Responsible for organizing, implementing and overseeing the CMC and Technical Operations Teams
• Highly sought after mentor and thought partner by GA and scientific teams for leadership and problem solving. Directly supported Chief Operations Officer, breaking creative ideas down into actionable steps and helping to codify the company vision and strategy

• Brigadier General select with Senate confirmation-declined promotion for transition to bio-tech sector
• Led $1B strategic enterprise with global reach, responsible officer for fifth generation transformation from F-16 to F-35 platform, oversaw $85M Payroll/Budget, managed more than 1100 employees and recognized as the #1/16 air wing for improving mission readiness, performance, improving safety and improving safety
• Directly responsible for six major organizations to include Operations, Medical, Logisitcs, Mission-Support, Legal and Finance
• Received Legion of Merit Medal for superior leadership and exceptionally meritorious conduct in the performance of outstanding services and achievements during wartime
• SECDEF Approval 2016 for no notice F-16 deployment in-support of operations in Iraq to remove ISIS

• Department Head selection early for exceptional leadership, Combat Military Fighter Pilot in F/A-18
• Received Navy Commendation Medal for outstanding leadership during invasion of Afghanistan. Early assignment to Maintenance Department Head, managed 210 Marines, and earned #1 Air Wing 9 recognition for high level of sortie production/operations; established new communications protocol for squadron
• Hand-picked for team to launch off aircraft carrier immediately after 9/11 attack to protect United States. Selected for prestigious Marine Air Weapons Tactic School Course reserved for top 5% of all fighter pilots. Selected as course Honor Graduate.

• Received Honor Graduate Navy Top Gun Adversary Course

• Ranked number #1 of 12 junior officers in squadron during two deployments in support of Pacific Operations - received Navy Marine Corps Achievement Medal for superior leadership

• Interacted with clients regarding animal health and performed diagnostic, medical treatment, emergency care and surgery